查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498771

個人化醫療生物標記市場，按適應症、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Personalized Medicine Biomarkers Market, By Indication, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 270 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年個人化醫療生物標記市場規模為149.0834億美元，2024年至2032年複合年成長率為14.30%。

個人化醫療生物標記市場-市場動態

由於慢性病盛行率的上升以及人們對預後預測重要性的日益認知，預計該市場將出現成長

癌症、心血管疾病、糖尿病和神經退化性疾病等慢性疾病在全球範圍內不斷增加。客製化醫學為這些疾病提供精確有效的治療方案，通常利用生物標記為個別患者量身訂做治療方案。根據美國國家衛生統計中心的數據，慢性病是指持續三個月或更長的疾病。由於一種或多種慢性健康問題，大約 4000 萬美國人的日常活動受到限制。預後生物標記有助於預測疾病結果，促進臨床環境中做出更明智的決策。此外，政府和私營部門對個人化醫療研究的加大投資支持了新生物標記和診斷工具的進步，為市場創造了成長機會。然而，與監管和報銷相關的挑戰可能會阻礙市場的擴張。

個人化醫療生物標記市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 14.30% 左右的複合年成長率成長

根據適應症細分，腫瘤學預計將在 2023 年顯示最大的市場佔有率

基於應用細分，2023年早期檢測/篩檢為主導類型

按地區分類，北美是 2023 年的主要收入來源

個人化醫療生物標記市場-細分分析：

全球個人化醫療生物標記市場根據適應症、應用、最終用戶和地區進行細分。

根據適應症，市場分為三個部分：神經病學、腫瘤學、糖尿病、心臟病學、自體免疫疾病和其他。該市場主要由腫瘤學領域主導。由於技術進步和對客製化治療方法的需求不斷成長，個人化醫療生物標記市場，特別是在腫瘤學領域，正在大幅成長。

根據應用，市場分為兩個部分：診斷、治療選擇、早期檢測/篩檢和監測。市場的主導部分是早期檢測/篩檢。早期檢測和篩檢生物標記的重要性怎麼強調都不為過，因為它們有助於在更早、更易於管理的階段識別疾病，從而改善患者的治療效果並降低醫療費用。

根據最終用戶，市場分為兩個不同的類別：醫院和診所以及其他實體。醫院、診所和診斷實驗室仍將是重要的最終用戶，利用生物標記來提高診斷精度和治療效果。

個人化醫療生物標記市場 - 地理洞察

從地理上看，該市場橫跨北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據對商業活動有貢獻的國家進一步細分。在個人化醫療需求不斷成長的推動下，該市場主要由北美主導。由於需要更有效和客製化的治療方案，北美特別關注個人化醫療。個人化醫療致力於個人化醫療保健，為每位患者量身訂做醫療決策和治療方案。根據《美國管理醫療雜誌》報道，2016 年至 2020 年整體成長顯著，市場上的個人化藥物數量從 132 種增加到 286 種。採用率不斷上升，歐洲成為第二大市場成長地區。

個人化醫療生物標記市場-競爭格局：

個人化醫療生物標記市場的競爭格局表現為各主要參與者之間的激烈競爭。這些公司正在研發方面進行大量投資，以發現新的生物標記並創建先進的診斷測試。這種持續的創新對於維持市場領先地位至關重要。基因組學、蛋白質組學和生物資訊學的快速發展正在推動市場向前發展。有效利用這些技術的公司可以獲得競爭優勢。在這個競爭激烈的市場中，主要參與者都在努力透過策略性措施進行創新並擴大其能力。持續的技術進步、策略合作以及注重獲得監管批准對於公司維持和加強其市場地位至關重要。

最近的發展：

2024 年 2 月 12 日星期一，雅培 (Abbott) 和 Fujirebio 宣佈建立合作夥伴關係，合作開發僅供研究使用的神經絲輕鏈 (NfL) 測試。兩家公司在聯合聲明中透露，這種神經學生物標記檢測將與 Abbott 的 Alinity I 儀器相容，並將可供從事證明 NfL 生物標記有效性研究的研究人員使用。目標是到 2025 年使該測試商業化，使其成為 Alinity I 系統的首次 RUO 檢測。

總部位於比利時梅赫倫的 Biocartis 公司最近宣布與默克雪蘭諾中東公司和默克沙烏地有限公司（默克集團在 MEA 地區的子公司）擴大聯盟。此次合作的主要目的是提高中東和北非患者進行 RAS 生物標記檢測的可近性。

目錄

第 1 章：個人化醫療生物標記市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 個人化醫療生物標記市場片段（按適應症）
    • 個人化醫療生物標記市場片段（按應用）
    • 最終用戶的個人化醫療生物標記市場片段
    • 按國家/地區分類的個人化醫療生物標記市場片段
    • 按地區分類的個人化醫療生物標記市場片段
  • 競爭洞察

第 3 章：個人化醫療生物標記主要市場趨勢

  • 個人化醫療生物標記市場促進因素
    • 市場促進因素的影響分析
  • 個人化醫療生物標記市場限制
    • 市場限制影響分析
  • 個人化醫療生物標記市場機會
  • 個人化醫療生物標記市場未來趨勢

第 4 章：個人化醫療生物標記產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：個人化醫療生物標記市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：個人化醫療生物標記市場格局

  • 個人化醫療生物標記市場佔有率分析，2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：個人化醫療生物標記市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 腫瘤學
    • 神經病學
    • 糖尿病
    • 自體免疫疾病
    • 心臟病學
    • 其他

第 8 章：個人化醫療生物標記市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 早期檢測/篩檢
    • 診斷
    • 治療選擇
    • 監控

第 9 章：個人化醫療生物標記市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 其他

第 10 章：個人化醫療生物標記市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 個性化醫療生物標記北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 個性化醫療生物標記歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區個人化醫療生物標記主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 個性化醫療生物標記拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 個性化醫療生物標記中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 個人化醫療生物標記產業

  • 競爭儀表板
  • 公司簡介
    • Siemens Healthineers
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Nexus-DX
    • Qiagen
    • PerkinElmer Inc.
    • Lifesign LLC
    • Merck & Co Inc.
    • Bio-Rad Laboratories, Inc.
    • EKF Diagnostics Holdings plc
    • Singulex Inc.
    • Signosis Inc.
    • BioSims Technologies
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina Inc.
    • Myriad Genetics, Inc.
    • Biomarker Technologies, Inc.
    • Danaher Corporation
    • Epigenomics AG
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2942

REPORT HIGHLIGHT

Personalized Medicine Biomarkers Market size was valued at USD 14,908.34 million in 2023, expanding at a CAGR of 14.30% from 2024 to 2032.

Personalized medicine, involving the use of biomarkers in clinical samples, is a fascinating field with important implications for drug development. Biomarkers act as measurable indicators of a biological state or condition, allowing for the prediction of disease risk, diagnosis of conditions, monitoring of disease progression, and guidance of treatment decisions. They are essential in personalized medicine, offering possibilities to improve patient outcomes through precise and individualized healthcare. Continuous progress in biomarker research and technology is driving the field ahead, leading to a future where treatments are tailored more and more to each patient's unique traits.

Personalized Medicine Biomarkers Market- Market Dynamics

The market is anticipated to experience growth due to the rising prevalence of chronic diseases and the increasing recognition of the significance of prognostic prediction

Chronic illnesses, such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders, are increasing on a global scale. Tailored medicine provides precise and efficient treatment options for these ailments, often utilizing biomarkers to customize therapies for individual patients. According to the U.S. National Center for Health Statistics, a chronic illness is a condition that persists for three months or longer. Approximately 40 million Americans face limitations in their daily activities due to one or more chronic health issues. Prognostic biomarkers aid in forecasting disease outcomes, facilitating more informed decision-making in clinical settings. Moreover, the heightened investment in personalized medicine research by both governmental and private sectors supports the advancement of new biomarkers and diagnostic tools, creating growth opportunities for the market. Nevertheless, challenges related to regulations and reimbursement may impede the market's expansion.

Personalized Medicine Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.30% over the forecast period (2024-2032)

Based on Indication segmentation, Oncology was predicted to show maximum market share in the year 2023

Based on application segmentation, Early Detection/Screening was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Personalized Medicine Biomarkers Market- Segmentation Analysis:

The Global Personalized Medicine Biomarkers Market is segmented based on Indication, Application, End-User, and Region.

The market is categorized into three segments based on Indication: Neurology, Oncology, Diabetes, Cardiology, Autoimmune Diseases, and Others. The market is primarily dominated by the Oncology segment. The personalized medicine biomarkers market, particularly in the field of oncology, is witnessing substantial growth owing to technological advancements and a rising need for customized treatment methods.

The market is categorized into two segments according to their application: Diagnosis, Treatment Selection, Early Detection/Screening, and Monitoring. The dominant segment in the market is Early Detection/Screening. The significance of early detection and screening biomarkers cannot be overstated as they facilitate the identification of diseases at an earlier and more manageable stage, leading to better patient outcomes and decreased healthcare expenses.

The market is segmented into two distinct categories based on the end-user: hospitals and clinics, and other entities. Hospitals, clinics, and diagnostic laboratories will remain crucial end-users, utilizing biomarkers to improve diagnostic precision and treatment effectiveness.

Personalized Medicine Biomarkers Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, driven by the increasing demand for personalized medicine. There is a notable focus on personalized medicine in North America, spurred by the necessity for more efficient and customized treatment options. Personalized medicine strives to individualize healthcare, tailoring medical decisions and treatments to each patient. As per the American Journal of Managed Care, there has been significant growth overall from 2016 to 2020, with the number of personalized medicines in the market increasing from 132 to 286. These medicines represented 25% of the new drugs approved by the FDA in 2019. Europe follows as the second largest region for market growth, attributed to the rising adoption of Companion Diagnostics.

Personalized Medicine Biomarkers Market- Competitive Landscape:

The competitive landscape of the personalized medicine biomarkers market is characterized by fierce competition among various key players. These companies are making significant investments in research and development to discover new biomarkers and create advanced diagnostic tests. This constant innovation is crucial to stay ahead in the market. The market is being driven forward by rapid advancements in genomics, proteomics, and bioinformatics. Companies that effectively utilize these technologies can gain a competitive edge. In this highly competitive market, major players are striving to innovate and expand their capabilities through strategic initiatives. Continuous technological advancements, strategic collaborations, and a focus on obtaining regulatory approvals are vital for companies to maintain and strengthen their positions in the market.

Recent Developments:

On Monday, February 12, 2024, Abbott and Fujirebio announced their partnership to collaborate on the development of a research-use-only test for the neurofilament-light chain (NfL). In a joint statement, the companies revealed that this neurology biomarker assay will be compatible with Abbott's Alinity I instrument and will be made accessible to researchers engaged in studies that demonstrate the effectiveness of the NfL biomarker. The objective is to make this test commercially available by 2025, marking it as the inaugural RUO assay for the Alinity I system.

Biocartis, a Mechelen-based company in Belgium, has recently revealed an expanded alliance with Merck Serono Middle East and Merck Saudi Ltd., both subsidiaries of Merck KGaA, in the MEA region. The main aim of this partnership is to improve the accessibility of RAS biomarker testing for patients in the Middle East and North Africa.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Siemens Healthineers

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Nexus-DX

Qiagen

PerkinElmer Inc.

Lifesign LLC

Merck & Co Inc.

Bio-Rad Laboratories, Inc.

EKF Diagnostics Holdings plc

Singulex Inc.

Signosis Inc.

BioSims Technologies

Agilent Technologies, Inc.

Thermo Fisher Scientific, Inc.

Illumina Inc.

Myriad Genetics, Inc.

Biomarker Technologies, Inc.

Danaher Corporation

Epigenomics AG

Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Diabetes
  • Autoimmune Diseases
  • Cardiology
  • Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Early Detection/Screening
  • Diagnosis
  • Treatment Selection
  • Monitoring

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and clinics
  • Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Personalized Medicine Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Personalized Medicine Biomarkers Market Snippet by Indication
    • 2.1.2. Personalized Medicine Biomarkers Market Snippet by Application
    • 2.1.3. Personalized Medicine Biomarkers Market Snippet by End-User
    • 2.1.4. Personalized Medicine Biomarkers Market Snippet by Country
    • 2.1.5. Personalized Medicine Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. Personalized Medicine Biomarkers Key Market Trends

  • 3.1. Personalized Medicine Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Personalized Medicine Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Personalized Medicine Biomarkers Market Opportunities
  • 3.4. Personalized Medicine Biomarkers Market Future Trends

4. Personalized Medicine Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Personalized Medicine Biomarkers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Personalized Medicine Biomarkers Market Landscape

  • 6.1. Personalized Medicine Biomarkers Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Personalized Medicine Biomarkers Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 7.1.2. Oncology
    • 7.1.3. Neurology
    • 7.1.4. Diabetes
    • 7.1.5. Autoimmune Diseases
    • 7.1.6. Cardiology
    • 7.1.7. Others

8. Personalized Medicine Biomarkers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Early Detection/Screening
    • 8.1.3. Diagnosis
    • 8.1.4. Treatment Selection
    • 8.1.5. Monitoring

9. Personalized Medicine Biomarkers Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and clinics
    • 9.1.3. Others

10. Personalized Medicine Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Personalized Medicine Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Personalized Medicine Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Personalized Medicine Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Personalized Medicine Biomarkers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Personalized Medicine Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Personalized Medicine Biomarkers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Siemens Healthineers
    • 11.2.2. F. Hoffmann-La Roche Ltd
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Nexus-DX
    • 11.2.5. Qiagen
    • 11.2.6. PerkinElmer Inc.
    • 11.2.7. Lifesign LLC
    • 11.2.8. Merck & Co Inc.
    • 11.2.9. Bio-Rad Laboratories, Inc.
    • 11.2.10. EKF Diagnostics Holdings plc
    • 11.2.11. Singulex Inc.
    • 11.2.12. Signosis Inc.
    • 11.2.13. BioSims Technologies
    • 11.2.14. Agilent Technologies, Inc.
    • 11.2.15. Thermo Fisher Scientific, Inc.
    • 11.2.16. Illumina Inc.
    • 11.2.17. Myriad Genetics, Inc.
    • 11.2.18. Biomarker Technologies, Inc.
    • 11.2.19. Danaher Corporation
    • 11.2.20. Epigenomics AG
    • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Personalized Medicine Biomarkers Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Personalized Medicine Biomarkers Market, by Indication 2019-2032 (USD Million)
  • TABLE Personalized Medicine Biomarkers Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Personalized Medicine Biomarkers Market, by Application 2019-2032 (USD Million)
  • TABLE Personalized Medicine Biomarkers Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Personalized Medicine Biomarkers Market, by End-User 2019-2032 (USD Million)
  • TABLE Personalized Medicine Biomarkers Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Personalized Medicine Biomarkers Market, by Region 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Medicine Biomarkers Market, by End-User, 2019-2032 (USD Million)